Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gaksch

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Medicine|March 4, 2016
Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive PatientsMartin R Grübler, Katharina Kienreich, Martin Gaksch, et al.
Nutrients|April 28, 2017
Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled TrialVerena Schwetz, Christian Trummer, Marlene Pandis, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 3, 2014
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implicationsAndreas Tomaschitz, Grzegorz Piecha, Eberhard Ritz, et al.
The American Journal of the Medical Sciences|February 4, 2015
Homoarginine in patients with primary hyperparathyroidismAndreas Tomaschitz, Nicolas Verheyen, Martin Gaksch, et al.
European Journal of Nutrition|April 1, 2018
Effects of vitamin D supplementation on FGF23: a randomized-controlled trialChristian Trummer, Verena Schwetz, Marlene Pandis, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2015
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension StudyNicolas D Verheyen, Katharina Kienreich, Martin Gaksch, et al.
Journal of Hypertension|July 6, 2016
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trialNicolas Verheyen, Astrid Fahrleitner-Pammer, Burkert Pieske, et al.
Hypertension (Dallas, Tex. : 1979)|March 25, 2015
Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trialStefan Pilz, Martin Gaksch, Katharina Kienreich, et al.
The American Journal of Clinical Nutrition|June 6, 2018
Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trialsKarin Ma Swart, Paul Lips, Ingeborg A Brouwer, et al.
Journal of Hypertension|April 12, 2016
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trialAndreas Tomaschitz, Nicolas Verheyen, Andreas Meinitzer, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Medicine|March 4, 2016
Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive PatientsMartin R Grübler, Katharina Kienreich, Martin Gaksch, et al.
Nutrients|April 28, 2017
Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled TrialVerena Schwetz, Christian Trummer, Marlene Pandis, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 3, 2014
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implicationsAndreas Tomaschitz, Grzegorz Piecha, Eberhard Ritz, et al.
The American Journal of the Medical Sciences|February 4, 2015
Homoarginine in patients with primary hyperparathyroidismAndreas Tomaschitz, Nicolas Verheyen, Martin Gaksch, et al.
European Journal of Nutrition|April 1, 2018
Effects of vitamin D supplementation on FGF23: a randomized-controlled trialChristian Trummer, Verena Schwetz, Marlene Pandis, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2015
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension StudyNicolas D Verheyen, Katharina Kienreich, Martin Gaksch, et al.
Journal of Hypertension|July 6, 2016
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trialNicolas Verheyen, Astrid Fahrleitner-Pammer, Burkert Pieske, et al.
Hypertension (Dallas, Tex. : 1979)|March 25, 2015
Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trialStefan Pilz, Martin Gaksch, Katharina Kienreich, et al.
The American Journal of Clinical Nutrition|June 6, 2018
Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trialsKarin Ma Swart, Paul Lips, Ingeborg A Brouwer, et al.
Journal of Hypertension|April 12, 2016
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trialAndreas Tomaschitz, Nicolas Verheyen, Andreas Meinitzer, et al.
Pageof 4